3,4-dihydroxymandelic acid has been researched along with methamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurer, HH; Meyer, MR; Schwaninger, AE; Zapp, J | 1 |
| Maurer, HH; Meyer, MR; Schwaninger, AE | 1 |
2 other study(ies) available for 3,4-dihydroxymandelic acid and methamphetamine
| Article | Year |
|---|---|
Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.
Topics: Cytosol; Dopamine; Hallucinogens; Humans; Kinetics; Mandelic Acids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sulfotransferases | 2011 |
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
Topics: Chromatography, Gas; Chromatography, Liquid; Humans; Isoenzymes; Kinetics; Lactates; Mandelic Acids; Mass Spectrometry; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sulfates; Sulfotransferases | 2011 |